Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 1, 2025Arquivos de Neuro-PsiquiatriaOpen Access

Levodopa-induced dyskinesia is still a major clinical problem in Brazilian movement disorder clinics

View Full Paper
Ask AI
Bookmark
Share

Authors

VTVítor TumasMBManuelina Mariana Capellari Macruz BritoVBVanderci Borges

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Tumas et al. (2025) studied this question.

synapsesocial.com/papers/6a72c198e5469ee92be28d67https://doi.org/10.1055/s-0045-1806922
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Dyskinesia Matters2019 · 71 citations
  2. 2The Unified Dyskinesia Rating Scale: Presentation and clinimetric profile2008 · 255 citations
  3. 3Levodopa-induced dyskinesia in Parkinson disease2018 · 104 citations
  4. 4Levodopa‐Induced Dyskinesias are Frequent and Impact Quality of Life in Parkinson's Disease: A 5‐Year Follow‐Up Study2024 · 21 citations
  5. 5Levodopa‐induced dyskinesia in Parkinson disease: Current and evolving concepts2018 · 346 citations